强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JNJ 强生

交易中 11-13 14:23:33 EST

286.12

+2.60

+0.92%

最高288.11	最低284.03	成交量266.39万
今开284.99	昨收283.52	日振幅1.44%
总市值6,893亿	流通市值6,880亿	总股本24.09亿
成交额7.63亿	换手率0.11%	流通股本24.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":286.12,"timestamp":1794597812183,"preClose":283.52,"halted":0,"volume":2663916,"delay":0,"changeRate":0.009170428893905272,"floatShares":2404573193,"shares":2409295102,"eps":6.58,"marketStatus":"交易中","change":2.6,"latestTime":"11-13 14:23:33 EST","open":284.99,"high":288.11,"low":284.03,"amount":762734959.8402,"amplitude":0.014391,"askPrice":286.15,"askSize":38,"bidPrice":286.09,"bidSize":370,"shortable":3,"etf":0,"ttmEps":6.58,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1794603600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":283.52,"dividendRate":0.018454,"preHourTrading":{"tag":"盘前","latestPrice":285,"preClose":283.52,"latestTime":"09:29 EST","volume":9139,"amount":2603176.5214,"timestamp":1794580195074,"change":1.48,"changeRate":0.00522,"amplitude":0.011282},"postHourTrading":{"tag":"盘后","latestPrice":283.8505,"preClose":283.52,"latestTime":"19:58 EST","volume":2810781,"amount":796913188.943799,"timestamp":1794531524656,"change":0.3305,"changeRate":0.001166,"amplitude":0.00254},"volumeRatio":0.472493,"impliedVol":0.2693,"impliedVolPercentile":0.6414},"requestUrl":"/m/hq/s/JNJ","defaultTab":"news","newsList":[{"id":"2683567502","title":"强生vs可口可乐：哪一家的股息增长纪录更稳？","url":"https://stock-news.laohu8.com/highlight/detail?id=2683567502","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683567502?lang=zh_cn&edition=full","pubTime":"2026-11-14 00:31","pubTimestamp":1794587460,"startTime":"0","endTime":"0","summary":"最近 12 个月，强生股息占自由现金流比例为 62%，可口可乐为 79%。可口可乐 2024、2025 财年股息支出均超过自由现金流；公司目前预计 2026 年自由现金流至少 130 亿美元。两周之后，可口可乐上调本年度自由现金流预期。但可口可乐曾连续两年股息超过自身现金流，强生从未接近这种危险状态。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-11-14/doc-iniyriip0826268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BJJMRZ35.SGD","LU1061106388.HKD","LU1066051498.USD","BK4532","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0957791311.USD","LU0985320562.USD","LU1894683264.USD","LU1196500208.SGD","BMED","LU0098860793.USD","LU1280957306.USD","LU1032955483.USD","LU0072461881.USD","LU1228905037.USD","LU2456880835.USD","LU2133065610.SGD","IE00BVYPNV92.GBP","LU0511384066.AUD","LU0689626769.HKD","LU0950375773.USD","LU1868836914.USD","LU2279689827.SGD","FTXH","LU2750360641.GBP","LU0058720904.USD","LU1145028129.USD","LU2237443895.HKD","LU1057294990.SGD","LU0061474960.USD","LU1496350502.SGD","BREW","IE00BDGV0183.EUR","LU0203347892.USD","XLP","IE00B42XCP33.USD","LU0289739343.SGD","LU0053666078.USD","LU2461242641.AUD","LU0661504455.SGD","LU2112291526.USD","LU1988902786.USD","TRUH","LU0345770993.USD","LU1121112475.USD","LU0225283273.USD","LU2097829019.USD","LU2129689514.USD","LU2360032135.SGD","IE00BLSP4239.USD","SG9999011175.SGD","BK4007","LU1261432733.SGD","LU1043141396.HKD","BK4559","LU1815333072.USD","LU0114720955.EUR","LU2264538146.SGD","LU2417539215.USD","LU0345769631.USD","LU1291159041.SGD","LU1430594728.SGD","IE00BBT3K403.USD","LU2403377893.USD","IE000F7OJYX1.SGD","LU0345770308.USD","LU2347655156.SGD","LU1064131342.USD","LU1914381329.SGD","SG9999014567.USD","LU1032466523.USD","LU2361045086.USD","SG9999001440.SGD","LU0289961442.SGD","LU2471134952.CNY","IXJ","SG9999013999.USD","SG9999002224.SGD","LU0210528500.USD","IE00B3T34201.USD","LU0640476718.USD","LU1244550577.SGD","LU0943347566.SGD","LU2125154935.USD","IE00B19Z3581.USD","LU2213496289.HKD","LU2430703095.HKD","LU1670710588.SGD","SGXZ57979304.SGD","LU2125154778.USD","IE00B19Z3B42.SGD","LU2602419157.SGD","BK4592","LU0738911758.USD","LU2505996509.AUD","JDOC","LU0323591593.USD","LU2129689431.USD","LU2430703251.USD","SPFE0main","IE000BZT7R73.USD","TRUO","SKO00main","BK4533","LU1670711123.USD","LU1670710661.SGD","LU2237957902.USD","IE00B3PB1722.GBP","SG9999014575.USD","LU2242646235.USD","LU1221951046.USD","LU0289739699.SGD","LU1989771016.USD","IE000WAW04H5.SGD","LU1244550494.USD","LU0889566641.SGD","LU2750360997.AUD","LU2756315664.SGD","LU1551013425.SGD","BK4568","LU0345769128.USD","LU0289960550.SGD","LU0432979614.USD","LU2592432038.USD","PBJ","LU0106261372.USD","LU1267930813.SGD","LU1732799900.SGD","LU1066051225.USD","LU0553294199.USD","LU0426412945.USD","LU1894683348.USD","LU0234570918.USD","LU0683600562.USD","SG9999004303.SGD","IE0000B7K699.USD","IE000M9KFDE8.USD","LU2237443978.SGD","LU0124676726.USD","SG9999014542.SGD","LU2237443622.USD","LU2242652126.USD","BK4585","FHLC","SG9999001176.SGD","LU2023250330.USD","LU0912757837.SGD","KO","LU0787776722.HKD","LU1920063259.USD","LU1868837136.USD","GDOC","IE00BGHQF631.EUR","LU1116320901.HKD","LU2237957811.SGD","LU0057025933.USD","LU1074936037.SGD","LU2236285917.USD","IE00BLSP4452.SGD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0689472784.USD","LU0545039389.USD","LU0466842654.USD","LU0792757196.USD","LU2471134523.USD","XLV","LU1778281490.HKD","SG9999003800.SGD","LU0472753341.HKD","LU0069063385.USD","LU2471134879.HKD","PJP","LU2506951875.HKD","IE00B1BXHZ80.USD","LU0265550359.USD","LU1674673691.USD","LU2361044865.SGD","FTXG","LU2108987350.USD","LU0096364046.USD","IHE","LU2401740654.USD","LU1551013342.USD","IE000SO60NU8.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","LU1003077747.HKD","SG9999015341.SGD","UGE","BK4177","IE0034235303.USD","LU0210536198.USD","LU1935042991.SGD","LU1718418525.SGD","LU0320765646.SGD","MEDX","BK4581","JNJ","BK4504","LU0175139822.USD","LU0994945656.USD","LU0823417653.USD","IE00BFXG1179.USD","BK4550","LU0070217475.USD","LU1066051811.HKD","LU1983299246.USD","LU0795875086.SGD","LU2237443465.HKD","IE0002141913.USD","LU1868836757.USD","LU2089984988.USD","LU0265550946.USD","LU2471134796.USD","LU1506573853.SGD","BK4610","LU0234572021.USD","LU0426417589.USD","IE00BN8TJ469.HKD","LU0820562030.AUD","LU1670711040.USD","LU1059921491.USD","SGXZ80539844.SGD","BK4534","VHT","LU0882574055.USD","LU1066053197.SGD","LU1868836591.USD","LU1674673428.USD","LU1929549753.HKD","SG9999002232.USD","LU1732800096.USD","LU0820561909.HKD","LU0061475181.USD","LU2361044949.HKD","SG9999014559.SGD","IE00B7SZLL34.SGD","LU1868837300.USD","LU1244550221.USD","SG9999001176.USD","LU1221951129.SGD","LU2896262040.SGD","IE0002270589.USD","LU0122379950.USD","SG9999015358.SGD","LU2468319806.SGD","LU0795875169.SGD","LU1228905540.USD","LU2129689605.HKD","IE00BZ1G4Q59.USD","LU2430703178.SGD","LU1585245621.USD","LU2506952170.USD","LU0006306889.USD","RXL","LU0545562505.USD","LU0949170772.SGD","LU1043141123.HKD","SGXZ23171101.USD","IE00BVYPNW00.USD","IE0001KFT4U8.USD","LU0820561818.USD","LU2756315318.SGD","LU1920062954.HKD","LU1116320737.USD","IE000MB6IJN5.SGD","LU1023059063.AUD","LU1162221912.USD","LU2505996681.GBP","LU0203345920.USD","LU0964807845.USD","LU2487616109.SGD","BK4588","LU1629891620.HKD","LU0162691827.USD","LU0868494617.USD","IE00B2B36J28.USD","LU2237443549.SGD","LU2237443382.USD","IYH","LU0823417737.USD","LU2242646821.SGD","LU2506951958.HKD","LU2506952097.USD","FSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682390787","title":"强生：Caplyta治疗组43.9%的患者在第3周达到YMRS评分改善≥50%，安慰剂组为23.7%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682390787","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682390787?lang=zh_cn&edition=full","pubTime":"2026-11-10 21:03","pubTimestamp":1794315796,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","LU2471134796.USD","RXL","BMED","LU1430594728.SGD","FTXH","LU1059921491.USD","LU2023250330.USD","LU1261432733.SGD","IE0000B7K699.USD","JDOC","PJP","XLV","JNJ","LU0787776722.HKD","LU1023059063.AUD","LU2430703178.SGD","LU0289961442.SGD","LU2756315318.SGD","LU2129689514.USD","BK4533","BK4504","LU0640476718.USD","GDOC","LU0683600562.USD","LU0689472784.USD","IE00BJT1NW94.SGD","LU0912757837.SGD","LU2896262040.SGD","IHE","LU1032955483.USD","LU1674673691.USD","IE000SO60NU8.SGD","FHLC","LU1732799900.SGD","LU0058720904.USD","IE000BZT7R73.USD","TRUH","LU2471134952.CNY","VHT","LU2430703251.USD","IE000MB6IJN5.SGD","IE00BLSP4239.USD","LU1061106388.HKD","SG9999001176.SGD","IXJ","LU2756315664.SGD","SG9999002232.USD","IYH","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682084386","title":"强生：安全性数据令人鼓舞，研究结果显示，随着该联合疗法进入第三阶段，其有望实现门诊给药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682084386","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682084386?lang=zh_cn&edition=full","pubTime":"2026-11-09 21:58","pubTimestamp":1794232687,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0426417589.USD","IXJ","LU1032466523.USD","TRUH","IE00BLSP4239.USD","LU1894683264.USD","MEDX","LU1267930813.SGD","LU1244550221.USD","BMED","IHE","LU0345769128.USD","LU0994945656.USD","IE00B19Z3B42.SGD","LU2468319806.SGD","JDOC","LU0882574055.USD","XLV","IE000M9KFDE8.USD","LU0795875086.SGD","LU2750360997.AUD","IYH","LU1043141123.HKD","LU2756315664.SGD","FHLC","LU1430594728.SGD","LU0553294199.USD","LU0545039389.USD","LU1074936037.SGD","GDOC","LU1043141396.HKD","IE000SO60NU8.SGD","PJP","RXL","JNJ","BK4588","LU2602419157.SGD","VHT","LU1066053197.SGD","LU0426412945.USD","BK4568","BK4533","LU0985320562.USD","FTXH","LU0203347892.USD","LU0289961442.SGD","LU2430703178.SGD","LU0234572021.USD","LU0432979614.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682386035","title":"强生：在晚期前列腺癌中，其研究性基于pasritamig的免疫联合疗法显示73%的PSA缓解率。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682386035","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682386035?lang=zh_cn&edition=full","pubTime":"2026-11-09 21:57","pubTimestamp":1794232656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0943347566.SGD","PSA","FHLC","JNJ","LU0289961442.SGD","LU1244550577.SGD","LU2505996509.AUD","LU1228905540.USD","IYH","BK4585","BK4504","IE00BLSP4239.USD","VHT","MEDX","GDOC","LU0689626769.HKD","PJP","JDOC","RXL","XLV","IHE","INDS","HAUS","REAI","LU0210528500.USD","BK4550","IE00B3T34201.USD","LU2112291526.USD","BMED","TRUH","IE00B19Z3581.USD","LU1032466523.USD","LU0994945656.USD","FTXH","IE00B4R5TH58.HKD","IE00BBT3K403.USD","REZ","IE0009355771.USD","IE00BKVL7J92.USD","IE000BZT7R73.USD","LU0949170772.SGD","LU2471134523.USD","IXJ","LU1121112475.USD","LU1145028129.USD","BK4559","LU0058720904.USD","LU0345769128.USD","LU1066051498.USD","LU1196500208.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681849423","title":"强生公布nipocalimab二期新数据，显示该药在干燥综合征中改善患者优先关注的症状。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681849423","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681849423?lang=zh_cn&edition=full","pubTime":"2026-11-08 11:08","pubTimestamp":1794107323,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0122379950.USD","BMED","IE00B19Z3581.USD","LU1894683348.USD","LU1244550577.SGD","JNJ","PJP","LU1059921491.USD","IE00BSNM7G36.USD","VHT","LU2592432038.USD","TRUH","LU1066051811.HKD","RXL","LU0289739699.SGD","LU2133065610.SGD","LU0057025933.USD","IE00BJT1NW94.SGD","FHLC","SG9999001176.USD","LU0072461881.USD","LU1551013425.SGD","IHE","LU0943347566.SGD","LU1066051498.USD","LU1244550221.USD","BK4559","IE000BZT7R73.USD","IE00B4R5TH58.HKD","LU1145028129.USD","GDOC","LU2023250330.USD","FTXH","LU0820561909.HKD","LU2089984988.USD","LU2213496289.HKD","XLV","IYH","JDOC","IE00BLSP4452.SGD","LU1935042991.SGD","MEDX","LU0426417589.USD","IXJ","IE0002270589.USD","LU0545039389.USD","IE000WAW04H5.SGD","BK4534","LU0912757837.SGD","LU2756315664.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681514860","title":"HALOZYME：强生公司RYBREVANT FASPRO获得FDA加速批准。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681514860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681514860?lang=zh_cn&edition=full","pubTime":"2026-11-06 22:59","pubTimestamp":1793977152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0009355771.USD","IE00B19Z3581.USD","LU1244550577.SGD","LU0426412945.USD","MEDX","IE00B1BXHZ80.USD","BK4568","XLV","IXJ","FTXH","LU1059921491.USD","LU1196500208.SGD","LU0432979614.USD","IE000MB6IJN5.SGD","LU2505996681.GBP","BK4534","JNJ","LU0792757196.USD","SG9999001176.USD","LU0345770308.USD","LU0787776722.HKD","LU1778281490.HKD","PJP","GDOC","LU1066051225.USD","LU0882574055.USD","LU1032466523.USD","IE00B4R5TH58.HKD","LU1221951046.USD","LU2505996509.AUD","BMED","JDOC","SG9999001440.SGD","LU0511384066.AUD","LABU","SG9999002232.USD","VHT","IE0002141913.USD","TRUH","LU0640476718.USD","FHLC","IE00BKVL7J92.USD","RXL","IHE","IYH","LU1732799900.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","LU0466842654.USD","LU2756315318.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681851345","title":"强生医疗科技首款国产电生理导航系统亮相进博会，开启“中国智造”新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2681851345","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681851345?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:06","pubTimestamp":1793955977,"startTime":"0","endTime":"0","summary":"第九届进博会现场，一项与心律失常患者相关的重要本新成果迎来中国首发。强生医疗科技旗下首款国产电生理导航系统今天正式亮相并举办上市发布会。这不仅意味着拥有三十余年历史的CARTO系统正式迈入“中国智造”阶段，也标志着国际领先电生理技术与中国制造能力实现进一步融合。对于许多普通人来说，“电生理导航系统”或许有些陌生。但对于房颤等心律失常患者而言，这是实现精准诊疗的重要工具。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611063924888343.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611063924888343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FTXH","LU0345769128.USD","LU0289739699.SGD","LU0210536198.USD","BK4568","IE00BJT1NW94.SGD","LU1551013342.USD","LU1043141123.HKD","LU0210528500.USD","LU0820561909.HKD","RXL","LU2471134523.USD","LU1718418525.SGD","BMED","BK4550","LU1280957306.USD","TRUH","LU2430703095.HKD","IXJ","MEDX","PJP","LU1674673691.USD","BK4581","LU1061106388.HKD","IE000MB6IJN5.SGD","HEAL","IE00BKVL7J92.USD","XLV","IE00B42XCP33.USD","IE00BVYPNW00.USD","GDOC","LU0289739343.SGD","LU0069063385.USD","LU0912757837.SGD","FHLC","JNJ","LU0320765646.SGD","IE0002270589.USD","IHE","JDOC","IYH","LU2505996509.AUD","LU0689472784.USD","LU1221951129.SGD","IE00BLSP4239.USD","LU0795875086.SGD","VHT","LU1244550577.SGD","EKG","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681330832","title":"外企看中国｜对话强生医疗科技中国区总裁：不只关注一台设备增加多少智能功能","url":"https://stock-news.laohu8.com/highlight/detail?id=2681330832","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681330832?lang=zh_cn&edition=full","pubTime":"2026-11-06 14:23","pubTimestamp":1793946200,"startTime":"0","endTime":"0","summary":"中新经纬11月5日电(董湘依)对于跨国企业而言，中国市场正在从重要的业务增长极向创新协同平台转变。在医疗科技领域，这种变化尤为明显。一方面，中国临床需求持续释放，为全球医疗创新提供了丰富的应用场景；另一方面，中国本土企业、科研机构和医疗机构的创新能力不断提升，也在改变跨国企业的研发与合作模式。“今天，中国已经成为强生医疗科技全球第二大市场和重要战略高地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611063924754897.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611063924754897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE000F7OJYX1.SGD","LU0320765646.SGD","LU0795875169.SGD","EKG","IE000WAW04H5.SGD","LU0122379950.USD","JNJ","XLV","RXL","IE00BKVL7J92.USD","IHE","IYH","PJP","MEDX","IE00BZ1G4Q59.USD","LU0964807845.USD","IE00B1BXHZ80.USD","VHT","IE00B4R5TH58.HKD","LU0426412945.USD","LU0210528500.USD","LU2129689514.USD","LU0124676726.USD","LU1935042991.SGD","HEAL","BMED","BK4007","IE000BZT7R73.USD","LU0472753341.HKD","IE0002270589.USD","LU0820561818.USD","LU2403377893.USD","SGXZ57979304.SGD","TRUH","LU0072461881.USD","LU0345769128.USD","FTXH","LU0058720904.USD","LU0985320562.USD","LU0820561909.HKD","JDOC","IXJ","BK4581","IE0000B7K699.USD","LU1221951129.SGD","GDOC","FHLC","LU0949170772.SGD","IE0001KFT4U8.USD","LU1929549753.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681838385","title":"强生头颈部癌症疗法获美国FDA加速批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2681838385","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681838385?lang=zh_cn&edition=full","pubTime":"2026-11-06 10:38","pubTimestamp":1793932708,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1066051498.USD","JDOC","GDOC","BK4592","IE00BJJMRZ35.SGD","IHE","LU1496350502.SGD","RXL","LU0070217475.USD","LU1057294990.SGD","XLV","LU0511384066.AUD","IE000BZT7R73.USD","FTXH","IE00B7SZLL34.SGD","IE000SO60NU8.SGD","TRUH","FHLC","LU2430703251.USD","SG9999001176.SGD","VHT","LU0795875169.SGD","LU1585245621.USD","LU0210528500.USD","BK4588","LU2592432038.USD","LU0820562030.AUD","IE0034235303.USD","MEDX","SGXZ80539844.SGD","LU0069063385.USD","LU2112291526.USD","LU0072461881.USD","LU0203345920.USD","IE00BJT1NW94.SGD","BK4534","JNJ","BMED","LU2750360997.AUD","LABU","LU1989771016.USD","LU1674673691.USD","IXJ","PJP","LU2347655156.SGD","LU1894683348.USD","LU0787776722.HKD","LU0289961442.SGD","LU0345769128.USD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681880626","title":"强生宣布美国FDA批准RYBREVANT FASPRO™作为首个且唯一用于晚期头颈癌的双靶向疗法。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681880626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681880626?lang=zh_cn&edition=full","pubTime":"2026-11-06 10:04","pubTimestamp":1793930653,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","LU2430703178.SGD","RXL","LU0057025933.USD","LU1585245621.USD","IE00B1BXHZ80.USD","LU2756315664.SGD","JNJ","LU2133065610.SGD","BK4588","LU0689472784.USD","IE00BBT3K403.USD","FHLC","IE00B2B36J28.USD","JDOC","LU2756315318.SGD","MEDX","PJP","LU2592432038.USD","SG9999001440.SGD","FTXH","LU1935042991.SGD","TRUH","LU0689626769.HKD","IYH","LU2129689431.USD","LU0545562505.USD","SG9999001176.SGD","LU1003077747.HKD","BK4585","LU1066051498.USD","LU1894683264.USD","LU2456880835.USD","XLV","IHE","LU1043141123.HKD","LU0738911758.USD","LABU","LU0058720904.USD","LU1228905037.USD","LU0345770308.USD","LU0345770993.USD","LU2347655156.SGD","LU1023059063.AUD","GDOC","LU1732800096.USD","IXJ","LU2213496289.HKD","LU1162221912.USD","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681044241","title":"强生(JNJ.US)肺动脉高压新药获批新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2681044241","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681044241?lang=zh_cn&edition=full","pubTime":"2026-11-05 16:58","pubTimestamp":1793869132,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FTXH","IE00BFXG1179.USD","IHE","RXL","LU0345769128.USD","LU0787776722.HKD","LU0820561909.HKD","FHLC","LU2468319806.SGD","LU2129689605.HKD","LU1674673691.USD","LU0545562505.USD","BMED","GDOC","IE00B4R5TH58.HKD","LU0820561818.USD","LU1585245621.USD","LU1280957306.USD","IYH","LU0053666078.USD","LU1032466523.USD","LU2487616109.SGD","LU0210528500.USD","VHT","LU1629891620.HKD","XLV","IXJ","LU2471134879.HKD","IE00BN8TJ469.HKD","MEDX","LU1935042991.SGD","BK4581","LU1674673428.USD","LU1121112475.USD","JDOC","LU1244550221.USD","LU0114720955.EUR","LU1003077747.HKD","TRUH","PJP","JNJ","LU1983299246.USD","LU0553294199.USD","IE000SO60NU8.SGD","LU0640476718.USD","IE000BZT7R73.USD","LU1261432733.SGD","LU0511384066.AUD","LU0069063385.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681206935","title":"库拉肿瘤股价下跌 18.5%，原因是强生公布了一款血液肿瘤疗法的相关数据。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681206935","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681206935?lang=zh_cn&edition=full","pubTime":"2026-11-05 01:45","pubTimestamp":1793814301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1244550494.USD","IE00BJJMRZ35.SGD","LU0689626769.HKD","LU1267930813.SGD","GDOC","LU1551013425.SGD","BK4532","LU1778281490.HKD","LU1121112475.USD","IE00BSNM7G36.USD","IE000M9KFDE8.USD","IE0034235303.USD","LU2756315318.SGD","BMED","TRUH","IE00BFXG1179.USD","LU0795875086.SGD","LU0792757196.USD","LU0994945656.USD","IXJ","VHT","LU1228905037.USD","MEDX","RXL","BK4534","SG9999002232.USD","IHE","XLV","FTXH","IE00BGHQF631.EUR","LU1023059063.AUD","LU2471134523.USD","IE00BFTCPJ56.SGD","IYH","LU1732799900.SGD","LU2430703095.HKD","JDOC","IE000WAW04H5.SGD","LU0210528500.USD","LU2417539215.USD","LU0545039389.USD","LU0426412945.USD","LU0162691827.USD","JNJ","LU1894683348.USD","LU2487616109.SGD","LU0234570918.USD","FHLC","PJP","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124991048","title":"异动解读｜强生盘中上涨3.07%，骨科业务与Smith+Nephew合并谈判结束","url":"https://stock-news.laohu8.com/highlight/detail?id=1124991048","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124991048?lang=zh_cn&edition=full","pubTime":"2026-11-05 01:36","pubTimestamp":1793813785,"startTime":"0","endTime":"0","summary":"11月5日，强生盘中上涨3.07%，报274.35美元/股，成交额11.17亿美元。消息面上，Smith+Nephew确认，双方今年稍早围绕强生骨科业务潜在合并的谈判已结束，强生骨科资产重组路径重新回到分拆或其他资本运作方案。此前强生管理层已表示，计划在年中完成髋膝关节业务分拆，并倾向推进相关业务拆分。与此同时，Smith+Nephew披露第三季度营收15.51亿美元，同比增长3.4%，并称仍将继续探索骨科业务战略选项。谈判终止意味着强生相关重组方向进一步明朗。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"强生盘中上涨，骨科合并谈判终止","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192326891","title":"异动解读｜强生盘前上涨3.06%，Smith+Nephew确认与强生骨科业务合并谈判结束","url":"https://stock-news.laohu8.com/highlight/detail?id=1192326891","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192326891?lang=zh_cn&edition=full","pubTime":"2026-11-04 21:22","pubTimestamp":1793798575,"startTime":"0","endTime":"0","summary":"11月4日，强生盘前上涨3.06%，报274.3786美元/股，成交额660.31万美元。消息面上，Smith+Nephew确认，双方今年稍早就强生骨科业务潜在合并的谈判已经结束。此前强生已表示，计划在2027年年中完成髋膝关节业务分拆，并倾向推进相关业务拆分。背景来看，Smith+Nephew当日披露第三季度营收15.51亿美元，同比增长3.4%，同时确认终止谈判，但仍将继续探索骨科业务战略选项。对强生而言，谈判终止意味着其骨科资产重组路径进一步回到分拆或其他资本运作方案。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"强生盘前上涨，骨科合并谈判终止","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680846317","title":"强生(JNJ.US)实验性Shockwave Javelin导管技术成功率达94%，或拓展复杂冠状动脉手术市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2680846317","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680846317?lang=zh_cn&edition=full","pubTime":"2026-11-02 10:39","pubTimestamp":1793587157,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，强生上周日公布了其实验性 Shockwave Javelin 导管临床试验的积极 30 天结果。30 天时，93.4% 的患者未发生主要心血管事件，包括心源性死亡、心脏病发作，或在受治动脉内恢复血流的手术。经影像发现的严重并发症发生在 1.3% 的患者中。对投资者而言，这些结果可能支持强生将其心血管器械组合拓展至更复杂的冠状动脉手术。Shockwave Javelin 导管利用超声波压力波碎裂硬化的钙化沉积物，或可让医生为严重狭窄的动脉做好置入支架的准备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IYH","LU0795875086.SGD","TRUH","LU0124676726.USD","LU1066053197.SGD","LU2430703095.HKD","PJP","LU0949170772.SGD","LU0057025933.USD","FHLC","LU2468319806.SGD","IXJ","JNJ","LU0114720955.EUR","VHT","LU1057294990.SGD","LU0122379950.USD","LU1066051811.HKD","IE00BLSP4239.USD","JDOC","LU0432979614.USD","LU0289739699.SGD","LU1629891620.HKD","IE00B4R5TH58.HKD","LU0345770308.USD","LU1430594728.SGD","LU2487616109.SGD","LU0345769631.USD","BMED","IHE","LU0912757837.SGD","LU0738911758.USD","LU2471134879.HKD","RXL","LU2602419157.SGD","MEDX","BK4585","LU1585245621.USD","IE00BJJMRZ35.SGD","IE00BKVL7J92.USD","LU0889566641.SGD","LU2756315664.SGD","XLV","GDOC","FTXH","IE000SO60NU8.SGD","LU1778281490.HKD","LU2129689605.HKD","LU2023250330.USD","LU2471134523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680658784","title":"强生(JNJ.US)实验性Shockwave Javelin导管技术成功率达94%，或拓展复杂冠状动脉手术市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2680658784","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680658784?lang=zh_cn&edition=full","pubTime":"2026-11-02 10:39","pubTimestamp":1793587157,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IXJ","LU2471134952.CNY","LU0072461881.USD","VHT","LU0162691827.USD","IHE","IE00BBT3K403.USD","LU0210528500.USD","LU0098860793.USD","IE00BFTCPJ56.SGD","PJP","IE00B4R5TH58.HKD","LU0683600562.USD","LU0985320562.USD","LU2403377893.USD","BMED","TRUH","LU1221951046.USD","LU0122379950.USD","IE00BFXG1179.USD","LU0640476718.USD","LU2756315664.SGD","IE00BVYPNW00.USD","IE00B19Z3581.USD","FTXH","LU1629891620.HKD","LU1732799900.SGD","LU0964807845.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU1221951129.SGD","LU2756315318.SGD","BK4592","LU0795875169.SGD","GDOC","JNJ","LU1043141396.HKD","BK4568","RXL","LU2471134523.USD","LU1551013425.SGD","JDOC","XLV","IYH","FHLC","BK4532","LU0053666078.USD","LU1003077747.HKD","MEDX","LU1228905540.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680201750","title":"强生报告称，在高风险经皮冠状动脉介入治疗中使用Impella装置取得了积极的生存率和治疗结果。","url":"https://stock-news.laohu8.com/highlight/detail?id=2680201750","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680201750?lang=zh_cn&edition=full","pubTime":"2026-11-01 21:05","pubTimestamp":1793538314,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","LU0069063385.USD","LU2487616109.SGD","FTXH","BK4007","IE0002270589.USD","IE00BJJMRZ35.SGD","JDOC","LU1551013425.SGD","LU2430703251.USD","LU2213496289.HKD","LU0820562030.AUD","LU2602419157.SGD","LU0689626769.HKD","GDOC","HART","LU0289739343.SGD","BK4592","RXL","IXJ","LU1778281490.HKD","LU0738911758.USD","LU2347655156.SGD","TRUH","LU1023059063.AUD","LU0795875086.SGD","LU0994945656.USD","LU1585245621.USD","IE000SO60NU8.SGD","LU1732800096.USD","BK4581","IYH","VHT","LU0210528500.USD","LU0345769631.USD","PJP","LU0545562505.USD","IE00BGHQF631.EUR","BMED","IHE","LU1145028129.USD","LU2430703095.HKD","FHLC","LU1074936037.SGD","LU0057025933.USD","XLV","LU1983299246.USD","LU2129689514.USD","JNJ","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678151082","title":"小摩维持强生(JNJ.US)“中性”评级：两款抗癌新药数据亮眼，但估值溢价制约上行空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2678151082","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678151082?lang=zh_cn&edition=full","pubTime":"2026-10-26 14:20","pubTimestamp":1792995646,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0689626769.HKD","PJP","FTXO","IE000M9KFDE8.USD","IHE","LU0149725797.USD","LU0792757196.USD","UYG","VFH","FTXH","IXG","LU2471134952.CNY","TFNS","IXJ","LU2417539215.USD","LU2237443465.HKD","GDOC","TRUF","IE0001KFT4U8.USD","XLV","LU0211331839.USD","BK4588","FHLC","LU0787776722.HKD","JPO","LU2237443978.SGD","TRUH","VHT","IYH","JDOC","LU1145028129.USD","IE00BJTD4V19.USD","RXL","LU1551013342.USD","BMED","JNJ","IYF","LU2505996681.GBP","JPMO","IE00BZ1G4Q59.USD","LU1363072403.SGD","FNCL","LU2750360997.AUD","XLF","KBWB","IYG","IE00B3PB1722.GBP","LU0859254822.USD","MEDX","LU2756315318.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678133182","title":"强生公司报告称，其首创的 RIPTAC™ 分子 JNJ-6143 在晚期前列腺癌中的肿瘤缓解率为 75%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2678133182","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678133182?lang=zh_cn&edition=full","pubTime":"2026-10-25 15:30","pubTimestamp":1792913436,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BLSP4452.SGD","LU0345770308.USD","LU0795875086.SGD","IE00BJJMRZ35.SGD","LU1732800096.USD","PJP","SGXZ57979304.SGD","GDOC","MEDX","IYH","RXL","LU0289739343.SGD","JDOC","LU0098860793.USD","LU1291159041.SGD","IHE","LU0683600562.USD","IE00B3PB1722.GBP","LU1244550577.SGD","SG9999001176.SGD","LU0234572021.USD","LU0689626769.HKD","IE00BKVL7J92.USD","LU2750360641.GBP","LU1894683348.USD","XLV","FHLC","LU1280957306.USD","LU2430703095.HKD","LU0345769128.USD","LU0234570918.USD","VHT","LU1066051498.USD","FTXH","BMED","SG9999002232.USD","LU2487616109.SGD","LU2129689431.USD","LU0964807845.USD","LU1066053197.SGD","LU1929549753.HKD","LU1629891620.HKD","LU1023059063.AUD","IE00B3T34201.USD","TRUH","LU1989771016.USD","LU2403377893.USD","JNJ","IXJ","LU1496350502.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185931589","title":"异动解读｜强生盘中上涨3.04%，多发性骨髓瘤新适应症在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1185931589","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185931589?lang=zh_cn&edition=full","pubTime":"2026-10-22 23:24","pubTimestamp":1792682688,"startTime":"0","endTime":"0","summary":"10月22日，强生盘中上涨3.04%，报265.61美元，成交额5.06亿美元。消息面上，公司宣布泰立珂在华新增适应症获批，用于既往至少接受过一线治疗、包含抗CD38单抗和来那度胺的复发或难治性多发性骨髓瘤成人患者，治疗阶段前移至首次复发。这意味着其为中国相关患者带来同类首创的免疫治疗新选择。结合公司此前上调全年业绩指引，以及近期器械与创新药进展持续落地，市场对其创新药管线商业化韧性预期有所增强。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"强生盘中上涨，骨髓瘤新适应症在华获批","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com;www.investor.jnj.com;www.factsabouttalc.com","stockEarnings":[{"period":"1week","weight":0.0411},{"period":"1month","weight":0.1404},{"period":"3month","weight":0.089},{"period":"6month","weight":0.2506},{"period":"1year","weight":0.4585},{"period":"ytd","weight":0.37}],"compareEarnings":[{"period":"1week","weight":0.0329},{"period":"1month","weight":-0.0269},{"period":"3month","weight":-0.0248},{"period":"6month","weight":0.0243},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.1103}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品，强调人类的健康和福祉。强生通过两个主要业务部门运营：创新药物和医疗技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.543478,"avgChangeRate":0.00367},{"month":2,"riseRate":0.521739,"avgChangeRate":-0.001555},{"month":3,"riseRate":0.586957,"avgChangeRate":0.015928},{"month":4,"riseRate":0.617021,"avgChangeRate":0.030422},{"month":5,"riseRate":0.468085,"avgChangeRate":-0.025771},{"month":6,"riseRate":0.510638,"avgChangeRate":0.0082},{"month":7,"riseRate":0.617021,"avgChangeRate":0.013867},{"month":8,"riseRate":0.531915,"avgChangeRate":0.005825},{"month":9,"riseRate":0.489362,"avgChangeRate":0.003353},{"month":10,"riseRate":0.702128,"avgChangeRate":0.021416},{"month":11,"riseRate":0.617021,"avgChangeRate":0.018113},{"month":12,"riseRate":0.652174,"avgChangeRate":0.01226}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}